BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6435919)

  • 1. Renal failure in myeloma: relationship with isoelectric point of immunoglobulin light chains.
    Melcion C; Mougenot B; Baudouin B; Ronco P; Moulonguet-Doleris L; Vanhille P; Beaufils M; Morel-Maroger L; Verroust P; Richet G
    Clin Nephrol; 1984 Sep; 22(3):138-43. PubMed ID: 6435919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term survival patients with acute and severe renal failure due to multiple myeloma.
    Pasquali S; Casanova S; Zucchelli A; Zucchelli P
    Clin Nephrol; 1990 Dec; 34(6):247-54. PubMed ID: 2073767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal histological lesions and clinical syndromes in multiple myeloma. Renal Immunopathology Group.
    Pasquali S; Zucchelli P; Casanova S; Cagnoli L; Confalonieri R; Pozzi C; Banfi G; Lupo A; Bertani T
    Clin Nephrol; 1987 May; 27(5):222-8. PubMed ID: 3109793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure.
    Hutchison CA; Plant T; Drayson M; Cockwell P; Kountouri M; Basnayake K; Harding S; Bradwell AR; Mead G
    BMC Nephrol; 2008 Sep; 9():11. PubMed ID: 18808676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Light chain nephropathy: histological and clinical aspects in 15 cases.
    Confalonieri R; Barbiano di Belgiojoso G; Banfi G; Ferrario F; Bertani T; Pozzi C; Casanova S; Lupo A; De Ferrari G; Minetti L
    Nephrol Dial Transplant; 1988; 3(2):150-6. PubMed ID: 3140081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe renal failure in multiple myeloma.
    Cosio FG; Pence TV; Shapiro FL; Kjellstrand CM
    Clin Nephrol; 1981 Apr; 15(4):206-10. PubMed ID: 7237869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Light-chain removal by plasmapheresis in myeloma-associated renal failure.
    Cserti C; Haspel R; Stowell C; Dzik W
    Transfusion; 2007 Mar; 47(3):511-4. PubMed ID: 17319833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple myeloma and light chain-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival.
    Abbott KC; Agodoa LY
    Clin Nephrol; 2001 Sep; 56(3):207-10. PubMed ID: 11597035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of urinary immunoglobulin light chain isoelectric point (pI) in nephrotoxicity in multiple myeloma.
    Coward RA; Delamore IW; Mallick NP; Robinson EL
    Clin Sci (Lond); 1984 Feb; 66(2):229-32. PubMed ID: 6420108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma: in vitro and in vivo studies.
    Hutchison CA; Cockwell P; Reid S; Chandler K; Mead GP; Harrison J; Hattersley J; Evans ND; Chappell MJ; Cook M; Goehl H; Storr M; Bradwell AR
    J Am Soc Nephrol; 2007 Mar; 18(3):886-95. PubMed ID: 17229909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute renal failure associated with a malignant lymphoproliferative disorder with monoclonal light chain immunoglobulin production. Report of a case.
    Berkel J; Granillo-Bodansky C; v d Borne AE
    Scand J Haematol; 1978 Apr; 20(4):377-83. PubMed ID: 418498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe renal failure in multiple myeloma.
    Cosio FG; Pence TV; Shapiro FL; Kjellstrand CM
    Proc Clin Dial Transplant Forum; 1980; 10():177-80. PubMed ID: 6810342
    [No Abstract]   [Full Text] [Related]  

  • 13. Haemodialysis using high cut-off dialysers for treating acute renal failure in multiple myeloma.
    Martín-Reyes G; Toledo-Rojas R; Torres-de Rueda Á; Sola-Moyano E; Blanca-Martos L; Fuentes-Sánchez L; Martínez-Esteban MD; Díez-de los Ríos MJ; Bailén-García A; González-Molina M; García-González I
    Nefrologia; 2012; 32(1):35-43. PubMed ID: 22294003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Survival of myeloma patients treated with dialysis].
    Martín Reyes G; Valera A; Frutos MA; Ramos B; Ordóñez V; López de Novales E
    Nefrologia; 2003; 23(2):131-6. PubMed ID: 12778877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma exchange therapy in acute renal failure due to light chain myeloma.
    Zucchelli P; Pasquali S; Cagnoli L; Rovinetti C
    Trans Am Soc Artif Intern Organs; 1984; 30():36-9. PubMed ID: 6442807
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunoglobulin light chain nephropathies.
    Sturgill BC; Tucker FL; Bolton WK
    Pathol Annu; 1987; 22 Pt 2():133-50. PubMed ID: 3120137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Approach to acute renal failure with multiple myeloma: role of plasmapheresis.
    El-Achkar TM; Sharfuddin AA; Dominguez J
    Ther Apher Dial; 2005 Oct; 9(5):417-22. PubMed ID: 16202018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of renal insufficiency in patients with multiple myeloma].
    Vulić D; Radlović O; Stanojcić A; Radmilović A; Rajić M
    Srp Arh Celok Lek; 1996; 124 Suppl 1():53-5. PubMed ID: 9102930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Renal insufficiency in myelomatosis. Causes and treatment].
    Knudsen LM; Hansen MT; Hippe E; Løkkegaard H
    Ugeskr Laeger; 1993 Nov; 155(47):3823-7. PubMed ID: 8256382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystalloid deposits in the kidney.
    Keller LS; Faull RJ; Smith P; Swift J; Bannister KM; Otto S; Peh CA
    Nephrology (Carlton); 2005 Feb; 10(1):81-3. PubMed ID: 15705186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.